296 related articles for article (PubMed ID: 24860650)
1. Cell-mediated immunity to human CMV infection: a brief overview.
Terrazzini N; Kern F
F1000Prime Rep; 2014; 6():28. PubMed ID: 24860650
[TBL] [Abstract][Full Text] [Related]
2. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
3. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
Front Immunol; 2022; 13():1008220. PubMed ID: 36341392
[TBL] [Abstract][Full Text] [Related]
4. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.
Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B
Front Immunol; 2023; 14():1143875. PubMed ID: 37187736
[TBL] [Abstract][Full Text] [Related]
5. Human Cytomegalovirus (HCMV)-Specific CD4
Jackson SE; Sedikides GX; Mason GM; Okecha G; Wills MR
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053099
[TBL] [Abstract][Full Text] [Related]
6. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
Front Immunol; 2014; 5():180. PubMed ID: 24795723
[TBL] [Abstract][Full Text] [Related]
7. The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.
Lim EY; Jackson SE; Wills MR
Front Cell Infect Microbiol; 2020; 10():202. PubMed ID: 32509591
[TBL] [Abstract][Full Text] [Related]
8. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
10. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus (CMV) Epitope-Specific CD4
Abana CO; Pilkinton MA; Gaudieri S; Chopra A; McDonnell WJ; Wanjalla C; Barnett L; Gangula R; Hager C; Jung DK; Engelhardt BG; Jagasia MH; Klenerman P; Phillips EJ; Koelle DM; Kalams SA; Mallal SA
J Immunol; 2017 Nov; 199(9):3187-3201. PubMed ID: 28972094
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
[TBL] [Abstract][Full Text] [Related]
13. CD8
Gaballa A; Arruda LCM; Rådestad E; Uhlin M
Stem Cells Int; 2019; 2019():6348060. PubMed ID: 31885619
[TBL] [Abstract][Full Text] [Related]
14. Control of murine cytomegalovirus infection by γδ T cells.
Sell S; Dietz M; Schneider A; Holtappels R; Mach M; Winkler TH
PLoS Pathog; 2015 Feb; 11(2):e1004481. PubMed ID: 25658831
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.
Chen KC; Stanton RJ; Banat JJ; Wills MR
J Virol; 2016 Jan; 90(6):3123-37. PubMed ID: 26739048
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells.
Vieira Braga FA; Hertoghs KM; van Lier RA; van Gisbergen KP
Eur J Immunol; 2015 Sep; 45(9):2433-45. PubMed ID: 26228786
[TBL] [Abstract][Full Text] [Related]
17. CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies.
Smith CJ; Quinn M; Snyder CM
Front Immunol; 2016; 7():352. PubMed ID: 27695453
[TBL] [Abstract][Full Text] [Related]
18. Single-cell transcriptomic and T cell antigen receptor analysis of human cytomegalovirus (hCMV)-specific memory T cells reveals effectors and pre-effectors of CD8
Kar R; Chattopadhyay S; Sharma A; Sharma K; Sinha S; Arimbasseri GA; Patil VS
Immunology; 2024 Jul; 172(3):420-439. PubMed ID: 38501302
[TBL] [Abstract][Full Text] [Related]
19. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
Boppana SB; Britt WJ
Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.
Wu Z; Frascaroli G; Bayer C; Schmal T; Mertens T
J Virol; 2015 Jun; 89(12):6435-41. PubMed ID: 25855747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
